HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: RAL-eve Study: Raltegravir Substitution Study [NA]
A completed clinical trial update (RAL-eve) evaluating substitution of raltegravir in HIV infection. Results were posted on 2011-10-28.
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection [Phase 2]
Phase 2 trial evaluating MK-0518 (raltegravir) intensification with histone deacetylase inhibition to deplete resting CD4+ T cell HIV infect…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
This clinical trial update reports findings from a pilot study characterizing how raltegravir distributes in cervicovaginal fluids of HIV-in…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Unboosted Atazanavir as Initial ART Therapy in China
A completed trial evaluating unboosted atazanavir as initial antiretroviral therapy in China.
-
FDA approval · 2011-10-21FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for SELZENTRY (maraviroc) submitted by ViiV Healthcare Company, updating the drug's labeling and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: Healthy Teen Girls: HIV Risk Reduction [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update on an HIV risk reduction intervention for healthy teen girls; the study has completed.
-
FDA approval · 2011-10-19FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP.
-
FDA approval · 2011-10-17FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) from E.R. Squibb & Sons, L.L.C., resulting in changes to the drug's lab…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Expanded Access Program for Maraviroc At Multiple Centers [Phase 3]
Expanded Access Program for maraviroc in HIV infections across multiple centers has completed. Phase 3 results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine [Phase 2]
This is a Phase 2 clinical trial update focusing on promoting safer sex practices among HIV-positive gay and bisexual men who use methamphet…
-
FDA approval · 2011-10-07FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
FDA approved a supplemental application for Etravirine submitted by Patriot Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients [NA]
This clinical trial update reports on the effectiveness of the Sci-B-Vac hepatitis B vaccine in HIV-positive individuals.
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV) [Phase 4]
Phase 4 NORTHIV trial comparing different antiretroviral regimens in ART-naïve people with HIV has completed.
-
CLINICAL_TRIALS research · 2011-10-04Clinical Trial Update: Lovastatin: Immunomodulatory Value Evaluation [Phase 2]
Phase 2 clinical trial evaluating the immunomodulatory effects of lovastatin in people with HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Evaluation of the Safety of a Polyvalent Virus in Healthy Adults [Phase 1]
Phase 1 safety evaluation of a polyvalent virus in healthy adults has completed; HIV infection is listed among the conditions studied.
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects [Phase 2]
Phase 2 trial evaluating nitazoxanide plus ribavirin and peginterferon for treatment-naive HIV coinfected subjects with Hepatitis C Genotype…
-
CLINICAL_TRIALS trial_result · 2011-09-19Clinical Trial Update: Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir [Phase 1]
This update reports the completion of a Phase 1 relative bioavailability study of a pediatric granule formulation of dolutegravir. The trial…
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated whether milk thistle treatment is more effective than no treatment in patients co-infected wi…
-
CLINICAL_TRIALS research · 2011-09-14Clinical Trial Update: Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure [NA]
A clinical trial update from Karolinska Institutet regarding antiretroviral treatment strategies in relation to adherence, resistance, and v…
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: An Expanded Safety Study of Dapivirine Gel 4759 in Africa [Phase 1, Phase 2]
An expanded safety study of Dapivirine Gel 4759 for HIV prevention completed across Phase 1 and Phase 2 in Africa.
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Integrating Buprenorphine Into the SFGH AIDS Program [Phase 4]
Phase 4 clinical trial update on integrating buprenorphine treatment into the San Francisco General Hospital AIDS Program for people with HI…
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use
A multicountry, multicenter post-marketing observational study evaluating Kaletra (lopinavir/ritonavir) in routine HIV-1 care, focusing on c…
-
CLINICAL_TRIALS withdrawal · 2011-09-09Clinical Trial Update: A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium [Phase 1]
A Phase 1 safety and pharmacokinetic study of a dapivirine and maraviroc gel for HIV infections in Belgium has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Cameroon Mobile Phone SMS Trial [NA]
The update notes the completion of a Cameroon-based mobile phone SMS trial assessing whether SMS reminders improve adherence among people li…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience [Phase 4]
A Phase 4 study evaluated adding enfuvirtide to ongoing HAART in HIV patients with prior treatment experience to assess safety and efficacy;…